Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CVS Health (CVS)

CVS Health Reports Third Quarter 2026 Results and Raises Full-Year Guidance

Positive Impact 4 of 5 guidance

CVS Health Corporation announced its third quarter 2026 financial results, reporting total revenues of $108.4 billion and a net income of $2.17 billion. Driven by strong performance across its Health Care Benefits and Pharmacy & Consumer Wellness segments, the company raised its full-year 2026 guidance.

Key points

  • Third quarter total revenues increased 5.4% year-over-year to $108.4 billion.
  • GAAP diluted EPS was $1.68 and Adjusted EPS was $2.09 for the third quarter of 2026.
  • Full-year 2026 GAAP diluted EPS guidance was raised to at least $6.98, and Adjusted EPS guidance was raised to at least $8.20.
  • Year-to-date cash flow from operations reached $15.3 billion as of September 30, 2026.

The filing

CompanyCVS Health (CVS)
Form8-K, current report
Filed with the SECNov 4, 2026, 6:31 AM ET
Accession number0000064803-26-000107

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Google Gemini, gemini-3.5-flash-lite) on Nov 4, 2026, 8:16 AM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.